SCHEMBL7585259

SCHEMBL7585259

NC(=O)NNc1cccc(Cl)c1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.69
GAA P10253 4/20 0.69
ALDH1A1 P00352 4/20 0.69
MEN1 O00255 7/20 0.56
KMT2A Q03164 7/20 0.56
LMNA P02545 3/20 0.56
HTT P42858 2/20 0.56
HTR3E A5X5Y0 2/20 0.54
HTR3B O95264 2/20 0.54
HTR3A P46098 2/20 0.54
HTR3D Q70Z44 2/20 0.54
HTR3C Q8WXA8 2/20 0.54
GFER P55789 1/20 0.54
RAB9A P51151 3/20 0.51
NPC1 O15118 2/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
KDM4E B2RXH2 1/20 0.51
NPY1R P25929 1/20 0.50
NPY2R P49146 1/20 0.50
TDP1 Q9NUW8 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pyridine SCHEMBL28293453 0.89 MAPT (0.56) MAPTGAAALDH1A1MEN1KMT2A
SCHEMBL20984323 0.85 MAPT (0.62) MAPTGAAALDH1A1MEN1KMT2A
SCHEMBL2137703 0.83 MAPT (0.61) MAPTGAAALDH1A1MEN1KMT2A
SCHEMBL9690067 0.81 GAA (1.00) MAPTGAAALDH1A1MEN1KMT2A
SCHEMBL167193 0.81 MEN1 (0.71) MAPTGAAALDH1A1MEN1KMT2A
SCHEMBL26105067 0.81 ALDH1A1 (0.53) MAPTGAAALDH1A1MEN1KMT2A
SCHEMBL5691420 0.79 DDX3X (0.58) MAPTGAAALDH1A1MEN1KMT2A
Ammonia Solution, Strong SCHEMBL28790660 0.79 MEN1 (0.69) MAPTGAAALDH1A1MEN1KMT2A
SCHEMBL2139137 0.79 MAPT (0.56) MAPTGAAALDH1A1MEN1KMT2A
SCHEMBL22091065 0.78 GAA (0.49) GAAALDH1A1MEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0797098-B1 Method for stabilizing bilirubin in control sera and calibrators ROCHE DIAGNOSTICS GMBH (DE) 2002-10-02 EP disclosed
US-5854073-A Stabilization of bilirubin in control sera and calibrators BOHRINGER MANNHEIM GMBH (DE) 1998-12-29 US disclosed
EP-0797098-A2 Method for stabilizing bilirubin in control sera and calibrators Roche Diagnostics GmbH (DE) 1997-09-24 EP disclosed
US-5196314-A Colorimetric, tetrazole compunds to reduce interference BOEHRINGER MANNHEIM GMBH (DE) 1993-03-23 US disclosed
EP-0239931-B1 PROCESS AND REAGENT FOR THE DETERMINATION OF SUBSTRATES OR ENZYME ACTIVITIES Roche Diagnostics GmbH (DE) 1992-03-18 EP disclosed
US-5013647-A Determination of enzyme substrate or enzyme activity, uric acid, creatinine BOEHRINGER MANNHEIM GMBH (DE) 1991-05-07 US disclosed
EP-0239931-A2 Process and reagent for the determination of substrates or enzyme activities Roche Diagnostics GmbH (DE) 1987-10-07 EP disclosed
EP-0161436-B1 REDOX INDICATORS Roche Diagnostics GmbH (DE) 1987-09-02 EP disclosed
US-4665023-A MEDICAL DIAGNOSIS BOEHRINGER MANNHEIM GMBH (DE) 1987-05-12 US disclosed
EP-0161436-A1 Redox indicators Roche Diagnostics GmbH (DE) 1985-11-21 EP disclosed
US-4297271-A CHROMAGEN IN A DIAGNOSTIC TEST FOR FECAL BLOOD; CHROMATOGRAPHY BOEHRINGER MANNHEIM GMBH (DE) 1981-10-27 US disclosed
US-4219336-A HYDROGEN PEROXIDE, GUAIACONIC ACID BOEHRINGER MANNHEIM GMBH (DE) 1980-08-26 US disclosed